Together, these results imply that the antibody response against preS differs from SHBs, demonstrating an increasing trend during PEG-IFNα treatment in patients undergoing HBsAg clearance.
← all excerpts
A preS2 aa1-26-specific humoural response marks functional cure in chronic HBV infection.
1
—
—